Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Lexaria Bioscience Corp. (NASDAQ: LEXX)
LEXX Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
342.40%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
21%
LEXX Stock Analysis
LEXX
PE Ratio:
LEXX
PEG Ratio:
Not Available
LEXX
Forward EPS Growth (12 month):
0.00%
LEXX
PS Ratio:
34.4
LEXX
PSG Ratio:
0.1
LEXX
Forward Revenue Growth (12 month):
400.00%
LEXX Articles
No data was found